CD8A and cancer: Although overexpressed PD‐L1 on cancer cell by IFN‐γ significantly contributes to the immunosuppressive TME, αPD‐1 antibody still binds to PD‐1 on circulating CD8+ cytotoxic T cells, leading to its effective antitumor efficacy.